DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: 006620)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,895.00
+80.00 (1.66%)
Nov 15, 2024, 9:00 AM KST

DongKoo Bio & Pharma Revenue

DongKoo Bio & Pharma had revenue of 61.31B KRW in the quarter ending June 30, 2024, with 17.17% growth. This brings the company's revenue in the last twelve months to 240.39B, up 20.49% year-over-year. In the year 2023, DongKoo Bio & Pharma had annual revenue of 215.69B with 10.62% growth.

Revenue (ttm)
240.39B
Revenue Growth
+20.49%
P/S Ratio
0.58
Revenue / Employee
641.05M
Employees
375
Market Cap
137.33B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023215.69B20.70B10.62%
Dec 31, 2022194.99B39.84B25.68%
Dec 31, 2021155.15B15.93B11.45%
Dec 31, 2020139.22B38.09B37.67%
Dec 31, 2017101.12B13.76B15.75%
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition